基石药业-B宣布,其本土生产的普拉替尼胶囊已正式开始在全国范围内进行商业化供应。这一举措标志着该产品在中国市场进入全面商业化的新阶段。
基石药业-B宣布,其本土生产的普拉替尼胶囊已正式开始在全国范围内进行商业化供应。这一举措标志着该产品在中国市场进入全面商业化的新阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.